Pacira BioSciences (NASDAQ:PCRX) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.56 by 7.14 percent. This is a 3.23 percent decrease over earnings of $0.62 per share from the same period last year. The company reported quarterly sales of $177.376 million which beat the analyst consensus estimate of $173.325 million by 2.34 percent. This is a 5.00 percent increase over sales of $168.923 million the same period last year.